$ABBV

AbbVie Faces Setback with Schizophrenia Drug Trials, Impacting Stock Performance

$ABBV AbbVie (NYSE:ABBV), a major player in the biopharmaceutical industry, recently faced a significant setback as its experimental schizophrenia drug,…